The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
MENTHOL, (plus)-, CAMPHOR, (-)-, and METHYL SALICYLATE · MENTHOL, (+)- 100 mg/g; CAMPHOR, (-)- 40 mg/g; METHYL SALICYLATE 300 mg/g · Cream · Topical · Genomma Lab USA
NDC 50066-0456-20 · 1 TUBE in 1 CARTON / 56.7 g in 1 TUBE · OTC MONOGRAPH DRUG · View full market →
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
sole-source market · price up 7% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Genomma Lab USA | MENTHOL, (+)- 100 mg/g; CAMPHOR, (-)- 40 mg/g; METHYL SALICYLATE 300 mg/g | Aug 26, 2026 | Sep 2, 2026 |
| Genomma Lab USA | MENTHOL, (+)- 40 mg/g; CAMPHOR, (-)- 100 mg/g; METHYL SALICYLATE 300 mg/g | Jul 22, 2026 | Aug 19, 2026 |
| Genomma Lab USA | CAMPHOR, (-)- 40 mg/g; MENTHOL, (+)- 100 mg/g; METHYL SALICYLATE 300 mg/g | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "XRay Pain Relief — NDC 50066-0456-20," retrieved September 3, 2026, https://drugdashboards.com/drug/50066045620.
Free to cite with attribution — see how the data is put together.